|
End-of-day quote
Shenzhen S.E.
2026-09-30
|
5-day change | 1st Jan Change | ||
| 6.500 CNY | +1.09% |
|
+1.25% | -18.24% |
| Market Cap | 4.04B 602M 535M 500M 456M 858M 57.98B 870M 6.05B 2.34B 29.53B 2.26B 2.21B 94.84B | P/E 2024 |
96.5x | P/E 2025 | 91.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.38B 206M 183M 171M 156M 294M 19.86B 298M 2.07B 803M 10.12B 775M 758M 32.49B | EV / Sales 2024 |
0.5x | EV / Sales 2025 | 0.72x |
| Free-Float |
49.16% | Yield 2024 |
1.52% | Yield 2025 | 1.26% |
| 1 day | +1.09% | ||
| 1 week | +1.25% | ||
| 1 month | -5.25% | ||
| 3 months | +7.79% | ||
| 6 months | -11.32% | ||
| Current year | -18.24% |
| 1 week | 6.36 |  | 6.54 |
| 1 month | 6.33 | | 6.84 |
| Current year | 5.67 | | 9.8 |
| 1 year | 5.67 | | 9.8 |
| 3 years | 5.38 | | 10.13 |
| 5 years | 5.38 | | 12 |
| 10 years | 5.38 | | 14.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hai Chen
CEO | Chief Executive Officer | 46 | 2022-07-07 |
Jian Wang
PRN | Corporate Officer/Principal | 53 | 2019-04-25 |
Ming Yi Jia
PRN | Corporate Officer/Principal | 53 | 2020-08-20 |
| Director | Title | Age | Since |
|---|---|---|---|
Yang Wang
BRD | Director/Board Member | 48 | 2023-06-27 |
Sheng Chen
CHM | Chairman | 57 | 2023-06-27 |
Yan Ping Gao
BRD | Director/Board Member | 63 | 2020-06-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.09% | +1.25% | -5.11% | -21.12% | 602M | |
| -0.62% | -2.71% | +39.30% | +114.07% | 1,025B | |
| -2.30% | -4.44% | +39.03% | +66.07% | 623B | |
| -0.63% | -1.96% | +6.36% | +74.38% | 459B | |
| -1.03% | -2.82% | +59.56% | +39.69% | 355B | |
| -0.34% | -3.44% | +22.37% | +40.25% | 336B | |
| -0.19% | -1.45% | +13.50% | +26.44% | 270B | |
| -0.45% | -4.29% | -3.53% | +9.72% | 247B | |
| -3.38% | +0.30% | +36.44% | +51.54% | 220B | |
| -1.04% | -1.46% | +32.70% | +96.82% | 183B | |
| Average | -0.88% | -1.69% | +24.06% | +49.79% | 371.88B | |
| Weighted average by Cap. | -1.05% | -2.11% | +30.38% | +69.50% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.28B 489M 434M 406M 370M 697M 47.07B 706M 4.91B 1.9B 23.97B 1.84B 1.8B 76.99B | 3.2B 476M 423M 396M 361M 679M 45.86B 688M 4.79B 1.85B 23.36B 1.79B 1.75B 75.01B |
| Net income | 40.41M 6.02M 5.35M 5M 4.56M 8.58M 580M 8.7M 60.49M 23.42M 295M 22.6M 22.11M 948M | 53.91M 8.03M 7.13M 6.67M 6.08M 11.45M 773M 11.6M 80.71M 31.24M 394M 30.15M 29.5M 1.26B |
| Net Debt | -2.45B -365M -325M -304M -277M -521M -35.18B -528M -3.67B -1.42B -17.92B -1.37B -1.34B -57.55B | -2.66B -396M -352M -329M -300M -564M -38.12B -572M -3.98B -1.54B -19.41B -1.49B -1.45B -62.35B |
Employees
5,716
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-30 | CN¥6.500 | +1.09% | 7,401,831 |
| 26-09-29 | CN¥6.430 | -0.46% | 7,753,200 |
| 26-09-28 | CN¥6.460 | +0.62% | 7,161,241 |
| 26-09-24 | CN¥6.420 | -1.08% | 7,149,900 |
| 26-09-23 | CN¥6.490 | -2.26% | 10,000,700 |
- Stock Market
- Stocks
- 000919 Stock
Select your edition
All financial news and data tailored to specific country editions
